General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Edwards LifeSciences(MODEST), Viscardia(MODEST), NXT(SIGNIFICANT), Daxor(SIGNIFICANT), Fire 1(SIGNIFICANT), Bodyport(MODEST), Bodyport(MODEST), Alleviant(SIGNIFICANT), Coridea(SIGNIFICANT), CVRx(SIGNIFICANT), SyMap(MODEST), Axontherapies(SIGNIFICANT), Pharmacosmos(SIGNIFICANT) SPEAKER'S BUREAU: Zoll(SIGNIFICANT), CVRX(MODEST), Boston Scientific(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: American Heart Association(NONE), Bayer(MODEST)

View Full Disclosure